triazoles has been researched along with Carcinosarcoma in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Arbea, L; Cano, D; Hernandez-Lizoain, JL; Idoate, MA; Jurado, M; Martin-Algarra, S; Martin-Romano, P; Paramo, JA | 1 |
Bellini, E; Berchuck, A; Bernasocchi, T; Bertoni, F; Bielski, CM; Broaddus, RR; Carney, ME; Carr, SA; Cascione, L; Catapano, CV; Civenni, G; El Tekle, G; Enchev, RI; Garraway, LA; Janouskova, H; Kryukov, GV; Losa, M; Moch, H; Mutch, DG; Napoli, S; Peter, M; Rinaldi, A; Schraml, P; Svinkina, T; Theurillat, JP; Udeshi, ND; Ulbricht, A; Wild, PJ; Winterhoff, BJN | 1 |
Baron, M; d'Anjou, J; Dessogne, P | 1 |
3 other study(ies) available for triazoles and Carcinosarcoma
Article | Year |
---|---|
Durable complete remission with aromatase inhibitor therapy in a patient with metastatic uterine carcinosarcoma with poor performance status and coagulation disorders: a case report.
Topics: Aromatase Inhibitors; Blood Coagulation Disorders; Bone Neoplasms; Carcinosarcoma; Female; Humans; Letrozole; Lymphatic Metastasis; Middle Aged; Nitriles; Remission Induction; Shock; Triazoles; Uterine Hemorrhage; Uterine Neoplasms | 2017 |
Opposing effects of cancer-type-specific SPOP mutants on BET protein degradation and sensitivity to BET inhibitors.
Topics: Acetanilides; Adenocarcinoma, Clear Cell; Animals; Apoptosis; Azepines; Carcinoma, Endometrioid; Carcinosarcoma; Cell Cycle Proteins; Cell Line, Tumor; Cell Proliferation; Chromatography, Liquid; Cullin Proteins; Drug Resistance, Neoplasm; Endometrial Neoplasms; Epigenesis, Genetic; Female; Heterocyclic Compounds, 3-Ring; Humans; Immunoblotting; Immunohistochemistry; Immunoprecipitation; Male; Mass Spectrometry; Mice, Nude; Molecular Targeted Therapy; Mutation; Neoplasm Transplantation; Neoplasms, Cystic, Mucinous, and Serous; Nuclear Proteins; Prostatic Neoplasms; Protein Serine-Threonine Kinases; Repressor Proteins; Reverse Transcriptase Polymerase Chain Reaction; RNA-Binding Proteins; Transcription Factors; Triazoles; Ubiquitination | 2017 |
[The uterine sarcoma, a new risk identified for tamoxifen].
Topics: Aged; Anastrozole; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Carcinosarcoma; Enzyme Inhibitors; Estrogen Receptor Modulators; Female; Humans; Metrorrhagia; Middle Aged; Neoplasms, Second Primary; Nitriles; Risk; Tamoxifen; Triazoles; Uterine Neoplasms | 2004 |